Literature DB >> 29767574

Right ventricular stroke work correlates with outcomes in pediatric pulmonary arterial hypertension.

Weiguang Yang1, Alison L Marsden1,2, Michelle T Ogawa1, Charlotte Sakarovitch1, Keeley K Hall1, Marlene Rabinovitch1, Jeffrey A Feinstein1,2.   

Abstract

Pulmonary arterial hypertension (PAH) is characterized by elevated pulmonary artery pressures (PAP) and pulmonary vascular resistance (PVR). Optimizing treatment strategies and timing for transplant remains challenging. Thus, a quantitative measure to predict disease progression would be greatly beneficial in treatment planning. We devised a novel method to assess right ventricular (RV) stroke work (RVSW) as a potential biomarker of the failing heart that correlates with clinical worsening. Pediatric patients with idiopathic PAH or PAH secondary to congenital heart disease who had serial, temporally matched cardiac catheterization and magnetic resonance imaging (MRI) data were included. RV and PA hemodynamics were numerically determined by using a lumped parameter (circuit analogy) model to create pressure-volume (P-V) loops. The model was tuned using optimization techniques to match MRI and catheterization derived RV volumes and pressures for each time point. RVSW was calculated from the corresponding P-V loop and indexed by ejection fraction and body surface area (RVSWEF) to compare across patients. Seventeen patients (8 boys; median age = 9.4 years; age range = 4.4-16.3 years) were enrolled. Nine were clinically stable; the others had clinical worsening between the time of their initial matched studies and their most recent follow-up (mean time = 3.9 years; range = 1.1-8.0 years). RVSWEF and the ratio of pulmonary to systemic resistance (Rp:Rs) values were found to have more significant associations with clinical worsening within one, two, and five years following the measurements, when compared with PVR index (PVRI). A receiver operating characteristic analysis showed RVSWEF outperforms PVRI, Rp:Rs and ejection fraction for predicting clinical worsening. RVSWEF correlates with clinical worsening in pediatric PAH, shows promising results towards predicting adverse outcomes, and may serve as an indicator of future clinical worsening.

Entities:  

Keywords:  clinical worsening; lumped parameter model; pressure-volume (P-V) loop; right ventricular failure; risk stratification

Year:  2018        PMID: 29767574      PMCID: PMC6432686          DOI: 10.1177/2045894018780534

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  23 in total

1.  Modeling of the Norwood circulation: effects of shunt size, vascular resistances, and heart rate.

Authors:  F Migliavacca; G Pennati; G Dubini; R Fumero; R Pietrabissa; G Urcelay; E L Bove; T Y Hsia; M R de Leval
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-05       Impact factor: 4.733

2.  Time-dependent ROC curves for censored survival data and a diagnostic marker.

Authors:  P J Heagerty; T Lumley; M S Pepe
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

3.  Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension.

Authors:  Titus Kuehne; Sevim Yilmaz; Paul Steendijk; Phillip Moore; Maarten Groenink; Maythem Saaed; Oliver Weber; Charles B Higgins; Peter Ewert; Eckard Fleck; Eike Nagel; Ingram Schulze-Neick; Peter Lange
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

4.  Three-dimensional hemodynamics in the human pulmonary arteries under resting and exercise conditions.

Authors:  Beverly T Tang; Tim A Fonte; Frandics P Chan; Philip S Tsao; Jeffrey A Feinstein; Charles A Taylor
Journal:  Ann Biomed Eng       Date:  2010-07-17       Impact factor: 3.934

5.  Lung transplantation in children with idiopathic pulmonary arterial hypertension: an 18-year experience.

Authors:  Brian S Goldstein; Stuart C Sweet; Jingnan Mao; Charles B Huddleston; R Mark Grady
Journal:  J Heart Lung Transplant       Date:  2011-05-28       Impact factor: 10.247

6.  Pulmonary arterial hypertension in children: Diagnostic work-up and challenges.

Authors:  E B Rosenzweig; J A Feinstein; T Humpl; D D Ivy
Journal:  Prog Pediatr Cardiol       Date:  2009-12

7.  Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies.

Authors:  Rosa Laura E van Loon; Marcus T R Roofthooft; Tammo Delhaas; Magdalena van Osch-Gevers; Arend D J ten Harkel; Jan L M Strengers; Ad Backx; Hans L Hillege; Rolf M F Berger
Journal:  Am J Cardiol       Date:  2010-07-01       Impact factor: 2.778

Review 8.  Evaluation, risk stratification, and management of pulmonary hypertension in patients with congenital heart disease.

Authors:  Jeffrey A Feinstein
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2009

9.  Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings.

Authors:  D Dunbar Ivy; Erika Berman Rosenzweig; Jean-Christophe Lemarié; Monika Brand; Daniel Rosenberg; Robyn J Barst
Journal:  Am J Cardiol       Date:  2010-11-01       Impact factor: 2.778

10.  Normal right- and left ventricular volumes and myocardial mass in children measured by steady state free precession cardiovascular magnetic resonance.

Authors:  Emanuela Valsangiacomo Buechel; Thomas Kaiser; Clare Jackson; Achim Schmitz; Christian J Kellenberger
Journal:  J Cardiovasc Magn Reson       Date:  2009-06-21       Impact factor: 5.364

View more
  2 in total

1.  Multilevel and multifidelity uncertainty quantification for cardiovascular hemodynamics.

Authors:  Casey M Fleeter; Gianluca Geraci; Daniele E Schiavazzi; Andrew M Kahn; Alison L Marsden
Journal:  Comput Methods Appl Mech Eng       Date:  2020-04-21       Impact factor: 6.756

2.  Data-driven computational models of ventricular-arterial hemodynamics in pediatric pulmonary arterial hypertension.

Authors:  Christopher Tossas-Betancourt; Nathan Y Li; Sheikh M Shavik; Katherine Afton; Brian Beckman; Wendy Whiteside; Mary K Olive; Heang M Lim; Jimmy C Lu; Christina M Phelps; Robert J Gajarski; Simon Lee; David A Nordsletten; Ronald G Grifka; Adam L Dorfman; Seungik Baek; Lik Chuan Lee; C Alberto Figueroa
Journal:  Front Physiol       Date:  2022-09-07       Impact factor: 4.755

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.